Product
FDA018-ADC
1 clinical trial
1 indication
Indication
Advanced/Metastatic Solid TumorsClinical trial
A PhaseⅠStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of FDA018-ADC in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2029-12-01